{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:04:54Z","timestamp":1781305494881,"version":"3.54.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Our aim was to compare epidemiological, clinical and treatment characteristics, and outcomes between patients with diagnoses of coronavirus disease 2019\u2013associated pulmonary aspergillosis (CAPA) or putative invasive pulmonary aspergillosis (PIPA), without hematological cancers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Retrospective, monocentric comparative observational cohort study, including nonhematological patients treated for invasive pulmonary aspergillosis between 2018 and 2022. Primary study end points were risk factors for 30-day mortality and clinical failure. To account for the imbalance in antifungal treatment allocation, a propensity score weighting approach was adopted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 209 patients were included, 93 (44.5%) with CAPA and 116 (55.5%) with PIPA; 144 (68.9%) we admitted to the intensive care unit. Patients with PIPA had higher Charlson Comorbidity Index values (mean [SD], 5.8 [2.6]; range, 0\u201314) and higher prevalences of chronic obstructive pulmonary disease (30.7%), solid cancer (36.8%), liver cirrhosis (12.3%), and concomitant immunosuppressive therapies (26.1%). Patients with CAPA received more invasive mechanical ventilation (70.5%) and corticosteroids (90.1%), more frequently had positive galactomannan (GM) results with bronchoalveolar lavage (80.5%), and had longer mean hospital stays (62.7 [SD, 52.1; range, 8\u2013276] days) and intensive care unit stays (36 [30.7; 2\u2013168] days). No differences in clinical cure or mortality rates were observed between groups. In multivariable analysis, isavuconazole was the only independent factor for clinical cure, reported also in the propensity score matching analysis (odds ratio, 0.41 [95% confidence interval, .16\u20131.03]; P = .06). A positive serum GM result was independently associated with 30-day mortality (hazard ratio, 1.78 [95% confidence interval, 1.02\u20133.10]; P = .04).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with CAPA have fewer comorbid conditions and higher fungal burden than those with PIPA, but clinical outcomes are similar between groups. Isavuconazole was an independent predictor for clinical cure, and serum GM positivity an independent predictor for 30-day mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaf159","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:14:52Z","timestamp":1741983292000},"source":"Crossref","is-referenced-by-count":3,"title":["Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment"],"prefix":"10.1093","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-5288-1516","authenticated-orcid":false,"given":"Sara","family":"Volpi","sequence":"first","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1166-2961","authenticated-orcid":false,"given":"Shaniko","family":"Kaleci","sequence":"additional","affiliation":[{"name":"Clinical and Experimental Medicine, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6922-5759","authenticated-orcid":false,"given":"Erica","family":"Franceschini","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cantergiani","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Orlando","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-7847","authenticated-orcid":false,"given":"Adriana","family":"Cervo","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4041-1459","authenticated-orcid":false,"given":"Andrea","family":"Bedini","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2494-464X","authenticated-orcid":false,"given":"Stefania","family":"Casolari","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Esperti","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6143-439X","authenticated-orcid":false,"given":"Davide","family":"Chemello","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Albertini","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cancian","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Buonadonna","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Baldi","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tonelli","sequence":"additional","affiliation":[{"name":"Respiratory Diseases Unit, Department of Medical and Surgical Sciences, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Busani","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Serio","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Brugioni","sequence":"additional","affiliation":[{"name":"Internal Medicine Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonello","family":"Pietrangelo","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences for Children and Adults, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Melegari","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pinelli","sequence":"additional","affiliation":[{"name":"Division of Internal and Emergency Medicine, University Hospital of Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Venturelli","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Venturelli","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Girardis","sequence":"additional","affiliation":[{"name":"Department of Anesthesia and Intensive Care Medicine, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sarti","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Laboratory, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1254-9995","authenticated-orcid":false,"given":"Marianna","family":"Meschiari","sequence":"additional","affiliation":[{"name":"Infectious Disease Department, University Hospital of Modena, University of Modena and Reggio Emilia , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"2025052712084794800_ofaf159-B1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B3","doi-asserted-by":"crossref","first-page":"myab064","DOI":"10.1093\/mmy\/myab064","article-title":"Aspergillosis: emerging risk groups in critically ill patients","volume":"60","author":"Kluge","year":"2021","journal-title":"Med Mycol"},{"key":"2025052712084794800_ofaf159-B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052712084794800_ofaf159-B5","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-2600(18)30274-1","article-title":"Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study","volume":"6","author":"Schauwvlieghe","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2025052712084794800_ofaf159-B6","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s11739-021-02705-z","article-title":"Putative invasive pulmonary aspergillosis within medical wards and intensive care units: a 4-year retrospective, observational, single-centre study","volume":"16","author":"Corcione","year":"2021","journal-title":"Intern Emerg Med"},{"key":"2025052712084794800_ofaf159-B7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/jof8040390","article-title":"Prevalence of COVID-19-associated pulmonary aspergillosis: critical review and conclusions","volume":"8","author":"Egger","year":"2022","journal-title":"J Fungi"},{"key":"2025052712084794800_ofaf159-B8","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"suppl 2","key":"2025052712084794800_ofaf159-B9","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19-associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B11","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1038\/s41598-023-31788-1","article-title":"Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies","volume":"13","author":"Hamed","year":"2023","journal-title":"Sci Rep"},{"key":"2025052712084794800_ofaf159-B12","author":"CLSI"},{"key":"2025052712084794800_ofaf159-B13","author":"CLSI"},{"key":"2025052712084794800_ofaf159-B14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"2025052712084794800_ofaf159-B15","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00134-024-07341-7","article-title":"Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM","volume":"50","author":"Bassetti","year":"2024","journal-title":"Intensive Care Med"},{"key":"2025052712084794800_ofaf159-B16","doi-asserted-by":"crossref","first-page":"ciae633","DOI":"10.1093\/cid\/ciae633","article-title":"Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis","author":"Hatzl","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B17","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s40121-023-00818-w","article-title":"A comparison of diagnostic criteria for invasive pulmonary aspergillosis in critically ill patients","volume":"12","author":"Liu","year":"2023","journal-title":"Infect Dis Ther"},{"key":"2025052712084794800_ofaf159-B18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S2213-2600(24)00151-6","article-title":"Influenza-associated and COVID-19-associated pulmonary aspergillosis in critically ill patients","volume":"12","author":"Feys","year":"2024","journal-title":"Lancet Respir Med"},{"key":"2025052712084794800_ofaf159-B19","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1128\/JCM.00942-12","article-title":"Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review","volume":"50","author":"Avni","year":"2012","journal-title":"J Clin Microbiol"},{"key":"2025052712084794800_ofaf159-B20","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/myc.13428","article-title":"Aspergillus-PCR in bronchoalveolar lavage\u2014diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients","volume":"65","author":"Mikulska","year":"2022","journal-title":"Mycoses"},{"key":"2025052712084794800_ofaf159-B21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/1040841X.2013.804033","article-title":"Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis","volume":"41","author":"Heng","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"2025052712084794800_ofaf159-B22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1164\/rccm.200704-606OC","article-title":"Galactomannan in bronchoalveolar lavage fluid","volume":"177","author":"Meersseman","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052712084794800_ofaf159-B23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/14737159.7.1.21","article-title":"Galactomannan antigen detection in the diagnosis of invasive aspergillosis","volume":"7","author":"Verdaguer","year":"2007","journal-title":"Expert Rev Mol Diagn"},{"key":"2025052712084794800_ofaf159-B24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/arm91030016","article-title":"Invasive pulmonary aspergillosis in coronavirus disease 2019 patients lights and shadows in the current landscape","volume":"91","author":"Tsotsolis","year":"2023","journal-title":"Adv Respir Med"},{"key":"2025052712084794800_ofaf159-B25","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/myc.13274","article-title":"Invasive aspergillosis in critically ill patients: review of definitions and diagnostic approaches","volume":"64","author":"Jenks","year":"2021","journal-title":"Mycoses"},{"key":"2025052712084794800_ofaf159-B26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.diagmicrobio.2018.08.005","article-title":"The performance of galactomannan in combination with 1,3-\u03b2-D-glucan or aspergillus-lateral flow device for the diagnosis of invasive aspergillosis: evidences from 13 studies","volume":"93","author":"Zhang","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2025052712084794800_ofaf159-B27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcrc.2017.03.025","article-title":"A prospective study of fungal biomarkers to improve management of invasive fungal diseases in a mixed specialty critical care unit","volume":"40","author":"Talento","year":"2017","journal-title":"J Crit Care"},{"key":"2025052712084794800_ofaf159-B28","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1055\/s-0040-1702210","article-title":"Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease exacerbations","volume":"41","author":"Bulpa","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"2025052712084794800_ofaf159-B29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/myc.13403","article-title":"Invasive fungal infections in acute and chronic liver impairment: a systematic review","volume":"65","author":"Lahmer","year":"2022","journal-title":"Mycoses"},{"key":"2025052712084794800_ofaf159-B30","doi-asserted-by":"crossref","first-page":"i39","DOI":"10.1093\/jac\/dkx032","article-title":"Invasive mould infections in the ICU setting: complexities and solutions","volume":"72","author":"Bassetti","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2025052712084794800_ofaf159-B31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/505870","article-title":"Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey","volume":"43","author":"Cornillet","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B32","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2025052712084794800_ofaf159-B33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/cid\/cit393","article-title":"The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis","volume":"57","author":"Fisher","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2025052712084794800_ofaf159-B34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12941-019-0311-3","article-title":"Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center","volume":"18","author":"Van Matre","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025052712084794800_ofaf159-B35","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"key":"2025052712084794800_ofaf159-B36","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1080\/03007995.2018.1502659","article-title":"Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis","volume":"34","author":"Herbrecht","year":"2018","journal-title":"Curr Med Res Opin"},{"key":"2025052712084794800_ofaf159-B37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/myc.13469","article-title":"Isavuconazole therapeutic drug monitoring in critically ill ICU patients: a monocentric retrospective analysis","volume":"65","author":"H\u00f6hl","year":"2022","journal-title":"Mycoses"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaf159\/62416289\/ofaf159.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf159\/62416289\/ofaf159.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/12\/4\/ofaf159\/62416289\/ofaf159.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:09:29Z","timestamp":1748362169000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaf159\/8078771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaf159","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2025,3,14]]},"article-number":"ofaf159"}}